Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02104310 · ClinicalTrials.gov registry record

A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas

A clinical trial of Malignant Glioma, sponsored by Mayo Clinic.

Active
Registry status
25
Enrollment target
1
Study location

NCT02104310: Active study of Malignant Glioma, sponsored by Mayo Clinic.

NCT02104310 is a study of Malignant Glioma that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 91-participant average among 40 other Malignant Glioma trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02104310, a study of Malignant Glioma, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
25 participants
Enrollment target
1
Study location

Study Summary

For most brain tumors, radiation treatment is guided by a Magnetic Resonance Imaging (MRI) scan. In this study, information from a special scan, called a Positron Emission Tomography/ Computed Tomography (PET/CT) scan using an amino acid called Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) will also be used. This type of scan has shown promise in being able to better distinguish tumor from normal brain tissue and may help to more accurately plan radiation treatment. This type of scan can also assist the radiation oncologist in identifying the most aggressive regions of the tumor. The goal of this study is to compare the 18F-DOPA PET/CT scan with the MRI scan for identifying where the disease is that needs to be treated with radiation.

Conditions Studied

Malignant Glioma

Interventions

  • DRUG Fluorine-18-L-dihydroxyphenylalanine

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2014-04
Est. Completion 2031-03

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02104310

The ClinicalTrials.gov registry entry for NCT02104310 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 40 other Malignant Glioma trials with a reported enrollment target (73% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Malignant Glioma appearing as the primary indexed condition, and to 1 intervention - of which Fluorine-18-L-dihydroxyphenylalanine is the first listed.

NCT02104310 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02104310 about?

NCT02104310 is a clinical study titled "A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas". For most brain tumors, radiation treatment is guided by a Magnetic Resonance Imaging (MRI) scan. In this study, information from a special scan, called a Positron Emission Tomography/ Computed Tomography (PET/CT) scan using an amino acid called Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) will al...

What is the current status of trial NCT02104310?

This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2014-04. Estimated completion is 2031-03.

What conditions does trial NCT02104310 study?

This clinical trial studies the following conditions: Malignant Glioma.

What interventions are being tested in trial NCT02104310?

The interventions under investigation include: Fluorine-18-L-dihydroxyphenylalanine (DRUG).

Who is sponsoring clinical trial NCT02104310?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02104310 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Glioma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Malignant Glioma

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.